GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Cash Receipts from Operating Activities

ISU Abxis Co (XKRX:086890) Cash Receipts from Operating Activities


View and export this data going back to 2009. Start your Free Trial

What is ISU Abxis Co Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


ISU Abxis Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ISU Abxis Co Ltd (XKRX:086890) » Definitions » Cash Receipts from Operating Activities
Traded in Other Exchanges
N/A
Address
3Fl. Kookje Bldg, 90-1 Daeshin-dong, Seodaemun-gu, Seoul, KOR, 120-160
ISU Abxis Co Ltd is engaged in developing and manufacturing therapeutic antibodies in South Korea. It offers Abciximab, Clotinab, Abcertin, and Fabagal used to treat incurable diseases such as cancer and rare diseases.